Ultrasound Guided Subclavian Vein Cannulation. Echogenic Needles Versus Non-echogenic Needles
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anesthesia
- Sponsor
- Oslo University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Time from skin puncture of the needle until aspiration of venous blood.
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Randomized controlled intervention study comparing echogenic needles with non echogenic needles for ultrasound guided venous access in the subclavian vein.
Detailed Description
Patients undergoing certain surgical procedures and patients in intensive care unit require a central venous catheter (CVC) for infusion of medicaments and for monitoring. Central venous access (CVA) can be performed both with a blind technique or an ultrasound guided technique. A common place for CVA is the subclavian vein. While many guidelines recommend the use of ultrasound for jugular access, there are no explicit recommendations for subclavian CVA For ultrasound guided CVA procedures good needle visualization is important to successfully place the needle and catheter in the correct position. Echogenic needles can give better needle visualization when performing ultrasound guided CVA procedures. Theoretically, the use of echogenic needles should improve performance time and success rates, and reduce complication rates due to a better needling control. The investigators will investigate the use of echogenic needles for vascular access. A prospective randomized controlled trial design will be used. Echogenic needles will be compared with non-echogenic (standard) needles. The main null hypothesis states that there is no difference in access time between the needles.
Investigators
Trine Kåsine
Principal investigator
Oslo University Hospital
Eligibility Criteria
Inclusion Criteria
- •undergoing a surgical procedure requiring a CVC Patients must be at least 18 years of age. Patients that have given informed written consent.
Exclusion Criteria
- •Patients that do not speak or understand Norwegian language.
- •Skin disease or infection affecting the whole-body surface or within the area of examination.
- •Patients with untreated coagulopathy
- •Known vascular abnormality
- •Any reason why, in the opinion of the investigators, the patient should not participate.
- •Subject participates in a potentially confounding drug or device trial during the course of the study.
Outcomes
Primary Outcomes
Time from skin puncture of the needle until aspiration of venous blood.
Time Frame: 10 sec - 240 sec
Time from skin puncture of the needle until aspiration of venous blood in the syringe. Time till venous access
Secondary Outcomes
- The anaesthetists subjective experience with needle visualization(3 min- 20 min)
- The anaesthetists subjective experience with the needle placement(3 minutes - 20 minutes)
- Number of skin punctures(60 sec - 600 sec)
- Localization of catheter tip in x-ray(1 day- 7 days)
- Success with venous access in first needling attempt(60 sec - 600 sec)
- Incidence of Treatment-Emergent Adverse Events, pneumothorax hematothorax(1 minutes- 1 day)
- Time from skin puncture until catheter in place(60 sec - 600 sec)
- Number of needling attempts before venous access(60 sec - 600 sec)
- The procedure was aborted(2 minutes - 20 minutes)
- Incidence of delayed Treatment-Emergent Adverse Events pneumothorax, hematothorax(5 minutes - 1 week)